Status:
UNKNOWN
Expression of CD44, PCNA and E-cadherin in Pterygium Tissue
Lead Sponsor:
Balikesir University
Conditions:
Pterygium
Eligibility:
All Genders
Brief Summary
Purpose: Pterygium is a common ocular surface disease defined by fibrovascular conjunctival growth extending onto the cornea. Its pathogenesis remains unclear. In severe cases, it may extend into the ...
Detailed Description
Methods:60 patients with pterygium will be enrolled in the study and conjunctival samples will be collected from 30 patients to form the control group. CD44, PCNA and E-cadherin expressions in surgica...
Eligibility Criteria
Inclusion
- patient with pterygium -
Exclusion
- patient with pseudopterygium
- \-
Key Trial Info
Start Date :
October 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06042296
Start Date
October 1 2023
End Date
January 1 2024
Last Update
September 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hümeyra Yildirim
Balıkesir, Turkey (Türkiye), 10100